Illumina's newest upgrades (a response to Life Tech?)

[GW_OK]

For those of you who haven't been monitoring the latest thread over in the Ion Torrent forum. From Twitter:
Illumina announces #HiSeq 2500: able to seq entire genome or 20 exomes in 24h. #JPM12 #GenomeInADay

Illumina introduces #MiSeq enhanced performance w/ 3-fold throughput increase (7 Gb), faster cycles & 250 bp PE reads. #JPM12


How exciting!


Edit:
@illumina is working on new chemistry. "chemistry B" which is their stab at single molecule detection. #JPM12

I wonder if this has something to do with this:

http://news.harvard.edu/gazette/story/2012/01/reading-life%E2%80%99s-building-blocks/

[ECO]

More specs from here:

The HiSeq 2500 offers:

-- Unprecedented Speed and Flexibility -- two modes allow researchers to generate 120 gigabases (Gb) of data in 27 hours, or 600 Gb in a standard HiSeq run.
-- High Quality Data- system uses the proven SBS chemistry that has made both the HiSeq 2000 and the MiSeq systems the most accurate next-generation sequencers.
-- Expanding Applications -- enables researchers to sequence a human genome or 20 exomes in a day, or 30 RNA sequencing samples in as little as five hours.
-- Industry Leading Simplicity and Ease-of-Use -- integrated cluster generation process enables a simplified workflow similar the MiSeq platform.
-- Upgradable from HiSeq 2000 -- through a simple, field-based upgrade priced at $50,000.

The Company also announced the following performance enhancements to the MiSeq personal sequencer:

-- Threefold Increase in Throughput -- capable of generating up to 7 Gb per run, expanding the number of applications and increasing sample throughput.
-- Longer and More Reads -- a new 500-cycle reagent kit supports 2 x 250 bp runs, generating over 15 million clusters per run and enabling more accurate small-genome assembly and small RNA sequencing projects.
-- Faster Run Times -- Faster cycle times enable rapid turnaround applications, allowing researchers to perform microbial identification sequencing in as little as 2 1/2 hours.

[athos10025]

Illumina's new offerings

From

http://finance.yahoo.com/news/Illumina-Introduces-HiSeq-bw-684034008.html?x=0

The HiSeq 2500 offers:

Unprecedented Speed and Flexibility – two modes allow researchers to generate 120 gigabases (Gb) of data in 27 hours, or 600 Gb in a standard HiSeq run.
High Quality Data- system uses the proven SBS chemistry that has made both the HiSeq 2000 and the MiSeq systems the most accurate next-generation sequencers.

Expanding Applications – enables researchers to sequence a human genome or 20 exomes in a day, or 30 RNA sequencing samples in as little as five hours.
Industry Leading Simplicity and Ease-of-Use – integrated cluster generation process enables a simplified workflow similar the MiSeq platform.
Upgradable from HiSeq 2000 – through a simple, field-based upgrade priced at $50,000.

The Company also announced the following performance enhancements to the MiSeq personal sequencer:

Threefold Increase in Throughput – capable of generating up to 7 Gb per run, expanding the number of applications and increasing sample throughput.

Longer and More Reads – a new 500-cycle reagent kit supports 2 x 250 bp runs, generating over 15 million clusters per run and enabling more accurate small-genome assembly and small RNA sequencing projects.
Faster Run Times – Faster cycle times enable rapid turnaround applications, allowing researchers to perform microbial identification sequencing in as little as 2 ½ hours.

[GenoMax]

"More/faster" makes for a good headline but is this really a "must have" for people who have existing systems?

I just want to explore what people are thinking after reading these specs.

"-- Upgradable from HiSeq 2000 -- through a simple, field-based upgrade priced at $50,000"

For those of you who are already heavily invested in HiSeq 2000's is this upgrade something you will consider seriously?

[Richard Finney]

Illumina's stock price took a hit this morning but recovered quickly :

http://finance.yahoo.com/q/bc?s=ILMN+Basic+Chart&t=5d

Note the huge increase in volume and sharp recovery.

I have few ideas; but I"m guessing there's some skeptics out there.

Any fastqs available?

[turnersd]

Here's the announcement from Illumina about the HiSeq 2500 "genome-in-a-day" machine http://investor.illumina.com/phoenix...757&highlight=

[GW_OK]

Double output with a turbo mode for impatient PI's?
Plus an incorporated cBot functionality?
Already considered, already budgeting for.

[krobison]

For clinical applications, the time for a HiSeq run is a significant impediment.

If the cost per genome doesn't go up, then upgrading machines is a route to higher throughput per machine (and sq ft of lab space) and could therefore be cost advantageous.

[ECO]

+1 krobison.

I will be very interested to see the per base pricing on the "Turbo" mode versus the "standard" longer run times. Clearly ILMN needs to get people stuffing more reagents into these big boxes...10-25 runs per year (as probably happens with most HiSeqs now) can't support a high growth business.

[scbaker]

Chemistry B?

For those of you who haven't been monitoring the latest thread over in the Ion Torrent forum. From Twitter:
Illumina announces #HiSeq 2500: able to seq entire genome or 20 exomes in 24h. #JPM12 #GenomeInADay

Illumina introduces #MiSeq enhanced performance w/ 3-fold throughput increase (7 Gb), faster cycles & 250 bp PE reads. #JPM12


How exciting!


Edit:
@illumina is working on new chemistry. "chemistry B" which is their stab at single molecule detection. #JPM12

I wonder if this has something to do with this:
http://news.harvard.edu/gazette/stor...ilding-blocks/

I've not heard anyone else talk about "chemistry B" or single molecule sequencing from ILMN. Can you share more?

[westerman]

+1 krobison.

I will be very interested to see the per base pricing on the "Turbo" mode versus the "standard" longer run times. Clearly ILMN needs to get people stuffing more reagents into these big boxes...10-25 runs per year (as probably happens with most HiSeqs now) can't support a high growth business.

I don't think that there will be much more in reagent costs on a per-run basis. On the other hand perhaps the machines would be run more frequently. Most of our runs are multiple-sample projects. We often have 6 PIs spread across the lanes all with multiple samples. This can be hard because all of the sample arrivals and sample prep need to be in, more-or-less, in lock step. If some samples don't arrive or don't pass QC then the entire run get puts on hold. Or we eat the costs and do a partial run. On the other hand if we could just do a 120 GB at the same cost and with shorter turn around then we would put fewer samples in the run thus having fewer problems.

The SOLID 5500 allows for partial running -- the flowcell can be partially used and then wait around for the next batch of work to be prepared. That flexibility with a high-end machine is very nice.

[BBoy]

I've not heard anyone else talk about "chemistry B" or single molecule sequencing from ILMN. Can you share more?

Yeah, this is what I am interested in too, don't have a pro subscription to Genomeweb and they seem to be the only ones that have commented on the SMS thing.

GW_OK, I seriously doubt this is related to the article you linked to. Much of the work at Harvard (Gene Golovchenko?) historically has been around sensing with tunneling currents. The translocation speed of DNA through the pore needs to be slowed down substantially to have a hope of single-base detection. This can probably achieved with appropriate biasing. Even then the vertical extent of solid state nanopores that can be fabricated in mass quantities with practical means today is such that stray fields above/below the nanopore average over as much as 10 bases, which makes it hopeless to deconvolute the original signal. The envisioned workaround is to use nanoelectrodes with nearly atomically sharp tips. However, this makes them susceptible to the spatial orientation of the DNA as it translocates. Furthermore the currents that the electrodes need to sustain are such that they are destroyed in relatively short times. None of this is to say that at some point in the future this technology will not become viable, but at the present time it is far away from commercialization, I belelive.

Illumina's SMS strategy is probably closely linked to whatever progress Oxford Nanopore is making, Illumina is an investor there.

[athos10025]

I don't think that there will be much more in reagent costs on a per-run basis. On the other hand perhaps the machines would be run more frequently. Most of our runs are multiple-sample projects. We often have 6 PIs spread across the lanes all with multiple samples. This can be hard because all of the sample arrivals and sample prep need to be in, more-or-less, in lock step. If some samples don't arrive or don't pass QC then the entire run get puts on hold. Or we eat the costs and do a partial run. On the other hand if we could just do a 120 GB at the same cost and with shorter turn around then we would put fewer samples in the run thus having fewer problems.

The SOLID 5500 allows for partial running -- the flowcell can be partially used and then wait around for the next batch of work to be prepared. That flexibility with a high-end machine is very nice.

Agreed. Illumina talked about this as a feature for clinical applications, but I think that this flexibility will be very much appreciated in academic cores.

[ymc]

So what is the latest per genome reagent cost for this new HiSeq 2500 machine?? Finally sub $1000??

[GW_OK]

Yeah, this is what I am interested in too, don't have a pro subscription to Genomeweb and they seem to be the only ones that have commented on the SMS thing.
...

Illumina's SMS strategy is probably closely linked to whatever progress Oxford Nanopore is making, Illumina is an investor there.

Illumina's optioned whatever Oxford Nanopore can come up with. Oxford Nanopore has licensed stuff that Golovchenko and Lieber have come up with. Lieber has recently published an interesting paper on nanopore sequencing in Nature Nanotechnology.

I think things might be further along than people imagine.